1. Home
  2. HIHO vs ACXP Comparison

HIHO vs ACXP Comparison

Compare HIHO & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

N/A

Current Price

$0.91

Market Cap

4.3M

Sector

Industrials

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.52

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
ACXP
Founded
1990
2017
Country
Hong Kong
United States
Employees
N/A
4
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.8M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
HIHO
ACXP
Price
$0.91
$1.52
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
42.6K
48.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.97%
N/A
EPS Growth
N/A
24.35
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.29
52 Week High
$2.21
$8.34

Technical Indicators

Market Signals
Indicator
HIHO
ACXP
Relative Strength Index (RSI) 41.93 23.69
Support Level $0.89 $0.31
Resistance Level $1.21 $2.89
Average True Range (ATR) 0.05 0.17
MACD 0.01 -0.01
Stochastic Oscillator 42.30 11.39

Price Performance

Historical Comparison
HIHO
ACXP

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: